{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:14:57Z","timestamp":1748909697747,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Immune reconstitution inflammatory syndrome (IRIS) is a constellation of inflammatory disorders that are unmasked after the initiation of anti-retroviral therapy (ART) in Human immunodeficiency virus (HIV) infected patients. Unmasking lymphoma IRIS is a relatively rare manifestation after initiation of anti-retroviral therapy.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>We report a 44-year-old male with HIV on 4\u00a0months of ART presenting with pyrexia of unknown origin with a diagnosis of unmasking Hodgkin\u2019s lymphoma IRIS stage IV with B symptoms. This case portrays the importance of recognizing the possibility of Hodgkin\u2019s lymphoma as a possible manifestation of IRIS within the first 6\u00a0months of initiation of ART.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Patients presenting with pyrexia of unknown origin and lymphadenopathy within the first 6\u00a0months of initiation of ART, lymphoma diagnosis should be on the high threshold of suspicion as portrayed by our case.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s43046-020-0019-7","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T08:03:17Z","timestamp":1580371397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unmasking lymphoma immune reconstitution inflammatory syndrome in a patient with pyrexia of unknown origin: a case report"],"prefix":"10.1186","volume":"32","author":[{"given":"Mansi","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2541-2055","authenticated-orcid":false,"given":"Bhanu Prasad","family":"Venkatesulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Sallam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanika","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indira","family":"Brar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"issue":"7","key":"19_CR1","doi-asserted-by":"publisher","first-page":"e11416","DOI":"10.1371\/journal.pone.0011416","volume":"5","author":"PM Grant","year":"2010","unstructured":"Grant PM, Komarow L, Andersen J, Sereti I, Pahwa S, Lederman MM, et al. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS One. 2010;5(7):e11416.","journal-title":"PLoS One"},{"issue":"5","key":"19_CR2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/QAD.0b013e3282f4a607","volume":"22","author":"DM Murdoch","year":"2008","unstructured":"Murdoch DM, Venter WD, Feldman C, Van Rie A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS. 2008;22(5):601\u201310.","journal-title":"AIDS"},{"issue":"4","key":"19_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/01.aids.0000161769.06158.8a","volume":"19","author":"SA Shelburne","year":"2005","unstructured":"Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC Jr, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005;19(4):399\u2013406.","journal-title":"AIDS"},{"issue":"5","key":"19_CR4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/sj.bjc.6604520","volume":"99","author":"S Franceschi","year":"2008","unstructured":"Franceschi S, Maso LD, Rickenbach M, Polesel J, Hirschel B, Cavassini M, et al. Kaposi sarcoma incidence in the Swiss HIV cohort study before and after highly active antiretroviral therapy. Br J Cancer. 2008;99(5):800\u20134.","journal-title":"Br J Cancer"},{"issue":"2","key":"19_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/cid\/ciu270","volume":"59","author":"S Gopal","year":"2014","unstructured":"Gopal S, Patel MR, Achenbach CJ, Yanik EL, Cole SR, Napravnik S, et al. Lymphoma immune reconstitution inflammatory syndrome in the center for AIDS research network of integrated clinical systems cohort. Clin Infect Dis. 2014;59(2):279\u201386.","journal-title":"Clin Infect Dis"},{"issue":"9119","key":"19_CR6","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(97)09028-4","volume":"351","author":"JJ Goedert","year":"1998","unstructured":"Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, et al. Spectrum of AIDS-associated malignant disorders. Lancet. 1998;351(9119):1833\u20139.","journal-title":"Lancet"},{"issue":"5","key":"19_CR7","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/cid\/cit369","volume":"57","author":"EL Yanik","year":"2013","unstructured":"Yanik EL, Napravnik S, Cole SR, Achenbach CJ, Gopal S, Olshan A, et al. Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. Clin Infect Dis. 2013;57(5):756\u201364.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"19_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1182\/blood-2011-02-339275","volume":"118","author":"E Lanoy","year":"2011","unstructured":"Lanoy E, Rosenberg PS, Fily F, Lascaux AS, Martinez V, Partisani M, et al. HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy. Blood. 2011;118(1):44\u20139.","journal-title":"Blood."},{"issue":"10","key":"19_CR9","doi-asserted-by":"publisher","first-page":"e77409","DOI":"10.1371\/journal.pone.0077409","volume":"8","author":"MA Kowalkowski","year":"2013","unstructured":"Kowalkowski MA, Mims MP, Amiran ES, Lulla P, Chiao EY. Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphoma. PLoS One. 2013;8(10):e77409.","journal-title":"PLoS One"},{"issue":"5","key":"19_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/apc.2012.0424","volume":"27","author":"D Gotti","year":"2013","unstructured":"Gotti D, Danesi M, Calabresi A, Ferraresi A, Albini L, Donato F, et al. Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy. AIDS Patient Care STDs. 2013;27(5):259\u201365.","journal-title":"AIDS Patient Care STDs"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-020-0019-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s43046-020-0019-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-020-0019-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:08:00Z","timestamp":1611878880000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-020-0019-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["19"],"URL":"https:\/\/doi.org\/10.1186\/s43046-020-0019-7","relation":{},"ISSN":["2589-0409"],"issn-type":[{"type":"electronic","value":"2589-0409"}],"subject":[],"published":{"date-parts":[[2020,1,30]]},"assertion":[{"value":"10 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent to publish this information was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}